Ardea Biosciences (RDEA) Posts Q3 Loss of $0.13, Tops Views
Ardea Biosciences, Inc. (NASDAQ: RDEA) reports Q3 EPS of $0.13, versus the analyst estimate of ($0.53). Revenue for the quarter was $ million, which compares to the estimate of $3.51 million.
Related Categories
EarningsStocks Mentioned
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
